Taisi
泰思
Report date: 2023/01/07 18:44:01
NME
Base Information
Drug NameTaisi
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesXuanwu Hospital Of Capital Medical University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A